Skip to main content
    A

    Alexandria Real Estate Equities Inc (ARE)

    Official site

    REAL ESTATE • REIT - OFFICE • NYSE

    $43.54
    -0.30 (-0.68%)

    Market Cap: $7.64B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Alexandria Real Estate Equities Inc (ARE) Earnings: Report Dates and Results

    Updated Oct 26, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    FFO per share for Alexandria Real Estate Equities (ARE) was $9.00 for 2025. In the quarter ended Sep 30, 2026, Alexandria Real Estate Equities reported EPS of $1.54, above the $1.52 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate. Alexandria Real Estate Equities is expected to report earnings on Jan 25, 2027.

    Earnings

    Performance (10Y)

    Beat Rate
    45%(17/38)
    Avg Surprise
    -1.40%
    Streak
    3 Q

    Upcoming Estimates

    Reports Jan 25, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.13
    Range-$0.21 - -$0.06
    7 analysts
    Revenue Consensus
    $643.32M
    Range$564.48M - $713.48M
    13 analysts
    Reports Apr 26, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.14
    Range-$0.28 - -$0.06
    4 analysts
    EPS Revisions
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.09-49.7%
    60d ago-$0.10-41.9%
    30d ago-$0.140.0%
    7d ago-$0.140.0%
    Current-$0.14
    Revenue Consensus
    $651.41M
    Range$651.11M - $651.70M
    2 analysts

    Next Report

    ARE has an expected report date of Jan 25, 2027.

    ARE Earnings Call

    The latest ARE earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 38 quarters below that had an estimate, ARE beat 17 and missed 21. Revenue for the quarter ended Sep 30, 2026 was $671.18M, down 10.7% from $751.94M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.54$1.52N/A+1.32%Beat+208.0%11 up, 0 downOct 26, 2026$671.18M
    Jun 30, 2026$1.73$1.65N/A+4.85%Beat+260.4%10 up, 0 downAug 3, 2026$662.78M
    Mar 31, 2026$2.10$0.14$0.04 - $0.28N/AN/A+311.8%50 up, 0 downApr 27, 2026$671.02M
    Dec 31, 2025-$6.35$0.30-$0.56 - $0.50N/AN/A-1020.3%7N/AJan 26, 2026$754.41M
    Sep 30, 2025$0.50$0.39$0.39 - $0.39+28.21%Beat-42.5%10 up, 1 downOct 27, 2025$751.94M
    Jun 30, 2025$0.48$0.63$0.63 - $0.63-23.81%Miss-45.5%10 up, 0 downJul 21, 2025$762.04M
    Mar 31, 2025$0.51$0.60$0.60 - $0.60-15.00%Miss-42.7%10 up, 1 downApr 28, 2025$758.16M
    Dec 31, 2024$0.69$0.90$0.90 - $0.90-23.33%Miss-15.9%11 up, 0 downJan 27, 2025$788.95M
    Sep 30, 2024$0.87$0.92N/A-5.43%Miss0.0%40 up, 0 downOct 21, 2024$791.61M
    Jun 30, 2024$0.88$0.61$0.61 - $0.91+44.26%Beat+72.5%40 up, 0 downJul 22, 2024$766.73M
    Mar 31, 2024$0.89$0.63$0.63 - $0.87+41.27%Beat+7.2%40 up, 0 downApr 22, 2024$769.11M
    Dec 31, 2023$0.82$0.80$0.29 - $0.86+2.50%Beat+164.5%40 up, 0 downJan 29, 2024$757.22M
    Sep 30, 2023$0.87$0.88$0.78 - $2.07-1.14%Miss+148.6%40 up, 0 downOct 23, 2023$713.79M
    Jun 30, 2023$0.51$0.39$0.02 - $0.89+30.77%Beat-34.6%40 up, 0 downJul 24, 2023$713.90M
    Mar 31, 2023$0.83$0.79$0.55 - $0.97+5.06%Beat+16.9%40 up, 0 downApr 24, 2023$700.79M
    Dec 31, 2022$0.31$0.74N/A-58.11%Miss-46.6%10 up, 0 downJan 30, 2023$670.28M
    Sep 30, 2022$0.35$0.76N/A-53.95%Miss-50.0%30 up, 0 downOct 24, 2022$659.85M
    Jun 30, 2022$0.78$0.67$0.64 - $0.68+16.42%Beat+6.8%30 up, 0 downJul 25, 2022$643.76M
    Mar 31, 2022$0.71$0.88$0.21 - $1.28-19.32%Miss-1.4%40 up, 0 downApr 25, 2022$615.07M
    Dec 31, 2021$0.58$0.56$0.40 - $1.01+3.57%Beat-6.5%40 up, 0 downJan 31, 2022$576.92M
    Sep 30, 2021$0.70$0.75$0.37 - $0.86-6.67%Miss+25.0%40 up, 0 downOct 25, 2021$547.76M
    Jun 30, 2021$0.73$0.61$0.41 - $0.78+19.67%Beat+23.7%5N/AJul 26, 2021$509.62M
    Mar 31, 2021$0.72$0.58$0.42 - $0.71+24.14%Beat+56.5%4N/AApr 26, 2021$479.85M
    Dec 31, 2020$0.62$0.65$0.38 - $0.99-4.62%Miss-3.1%5N/AFeb 1, 2021$463.72M
    Sep 30, 2020$0.56$0.84N/A-33.33%Miss-9.7%3N/AOct 26, 2020$545.04M
    Jun 30, 2020$0.59$0.54$0.30 - $0.76+9.26%Beat+1.7%5N/AJul 27, 2020$436.96M
    Mar 31, 2020$0.46$0.74$0.50 - $0.74-37.84%Miss-16.4%4N/AApr 27, 2020$439.92M
    Dec 31, 2019$0.64$0.61$0.43 - $0.72+4.92%Beat+56.1%3N/AFeb 3, 2020$408.11M
    Sep 30, 2019$0.62$0.20$0.20 - $0.80+210.00%Beat-25.3%4N/AOct 28, 2019$390.48M
    Jun 30, 2019$0.58$1.00N/A-42.00%Miss+28.9%3N/AJul 29, 2019$373.86M
    Mar 31, 2019$0.55$0.60N/A-8.33%Miss+17.0%1N/AApr 29, 2019$358.84M
    Dec 31, 2018$0.41$0.55$0.49 - $0.55-25.45%Miss-8.9%3N/AFeb 4, 2019$340.46M
    Sep 30, 2018$0.83$0.57N/A+45.61%Beat+107.5%3N/AOct 29, 2018$341.82M
    Jun 30, 2018$0.45$0.55$0.49 - $0.64-18.18%Miss+12.5%5N/AJul 30, 2018$325.03M
    Mar 31, 2018$0.47$0.51$0.48 - $0.54-7.84%Miss+56.7%5N/AApr 30, 2018$320.14M
    Dec 31, 2017$0.45$0.40$0.37 - $0.42+12.50%BeatN/A5N/AJan 29, 2018$298.79M
    Sep 30, 2017$0.40$0.42$0.37 - $0.47-4.76%Miss+90.5%5N/AOct 30, 2017$285.37M
    Jun 30, 2017$0.40$0.41$0.39 - $0.50-2.44%Miss+2.6%4N/AJul 31, 2017$273.06M
    Mar 31, 2017$0.30$0.41N/A-26.83%Miss-14.3%N/AN/AMay 1, 2017$270.88M
    Dec 31, 2016-$0.16$0.41N/A-139.02%Miss-135.6%N/AN/AJan 30, 2017$249.16M
    Last 40 quarters

    Annual FFO

    FFO per share was $9.00 for 2025, down 0.1% from $9.01 in 2024. It was $5.25 for 2016, the oldest of the 10 years shown.

    Fiscal yearFFO per shareChange
    2025$9.00-0.1%
    2024$9.01+7.0%
    2023$8.42+8.5%
    2022$7.76+6.3%
    2021$7.30+4.9%
    2020$6.96+5.5%
    2019$6.60+9.6%
    2018$6.02+9.3%
    2017$5.51+5.0%
    2016$5.25N/A

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.86, after $3.33 the year before. It was $0.79 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.86-245.9%
    Dec 31, 2024$3.33+9.9%
    Dec 31, 2023$3.03+40.9%
    Dec 31, 2022$2.15-21.2%
    Dec 31, 2021$2.73+22.4%
    Dec 31, 2020$2.23-6.7%
    Dec 31, 2019$2.39+10.6%
    Dec 31, 2018$2.16+39.4%
    Dec 31, 2017$1.55+96.2%
    Dec 31, 2016$0.79N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,600 words across 15 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20267,64215
    2026Q2Jun 30, 20269,67516
    2026Q1Mar 31, 202611,01118
    2025Q4Dec 31, 20258,04017
    2025Q3Sep 30, 20258,18715
    2025Q2Jun 30, 20254,92915
    2025Q1Mar 31, 20256,27815
    2024Q4Dec 31, 202410,01516

    2026Q3 Earnings Call

    Opening remarks

    Paula Schwartz Investor Relations Thank you, and good afternoon, everyone. This conference call contains forward-looking statements within the meaning of the federal securities laws. The company's actual results might differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause results to differ materially from those in the forward-looking statements is contained in the company's periodic reports filed with the Securities and Exchange Commission. I now would like to turn the call over to Joel Marcus, Executive Chairman and Founder. Please go ahead, Joel.

    Joel Marcus Executive Chairman and Founder Thank you, Paula, and good day, everybody, and welcome to Alexandria's third quarter earnings call. First of all, I want to thank each and every member individually and collectively of the Alexandria team for a very solid third quarter 2026. As a family team, we've impacted the lives of countless patients here in the United States and around the world, and thank you for your commitment to the life science sector through real estate venture capital that has really transformed the impact on the growth and success of this amazing industry. And with that, I'd like to highlight a couple of key thoughts before turning it over to Marc Binda, our Chief Financial Officer, to recap the quarter. First of all, under the category of demand and leasing, we had a solid third quarter, leasing over 1.2 million square feet. Notably, we had a weighted average lease term of about 11 years, which is pretty great. And we had the second-highest filling of vacant space in the company's history. Seventy-four percent of our leasing was with existing tenants. We do have the largest life science tenant base in the industry, and it was quite well balanced except for public biotech, but we expect that to contribute importantly to fourth quarter projected leasing of about 1.25 million square feet. Helpful was the defeat of the cap on indirect costs, an issue that we have talked about many times, and the circuit court essentially beating off that cap helped drive institutional demand and leasing this quarter. One interesting indicator: people always wonder about the potential for public biotech health. Rather than the XBI, I think people should look at what's called the BBC ETF, about 129 stocks, 93% of which are clinical stage, which I think reflects the public biotech sector probably more realistically. Clinical-stage biotech valuations still remain well below historical averages. There's been a good contribution this quarter from advanced technology companies, as they're very attracted to our Megacampuses for their recruitment and retention as well as our wonderful infrastructure, which is quite well suited to their businesses.

    Frequently Asked Questions About ARE

    When is Alexandria Real Estate Equities's next earnings date?

    Alexandria Real Estate Equities's next earnings report is expected for Jan 25, 2027.

    Did ARE beat earnings estimates last quarter?

    Yes. Alexandria Real Estate Equities reported EPS of $1.54 for the quarter ended Sep 30, 2026, above the $1.52 estimate, a 1.32% surprise.

    What EPS do analysts expect from ARE next quarter?

    The consensus EPS estimate for Alexandria Real Estate Equities for the quarter ending Dec 31, 2026 is -$0.13 from 7 analysts, with estimates from -$0.21 to -$0.06.

    How often does ARE beat earnings estimates?

    Alexandria Real Estate Equities beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +1.38%.